Protex acquires control of Suzhou-Prox-Anli

Paintindia Group

首页> 外文期刊>Paintindia >Protex acquires control of Suzhou-Prox-Anli

【24h】

Protex acquires control of Suzhou-Prox-Anli

机译：Protex取得苏州-安利-安利的控制权

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Protex International has recently acquired the shares owned by Rhodia in the Suzhou-Rhodia-Anli Specialty Chemicals joint-venture. The plant of Suzhou in the jiang Su province in China will continue to operate under the SuzHou-Rhodia-Anli Specialty Chemicals joint-venture.

机译：Protex International最近已在苏州-罗地亚-安利特种化学品合资公司中收购了罗地亚所拥有的股份。在中国江苏省苏州市的工厂将继续在SuzHou-Rhodia-Anli特种化学品合资企业下运营。

著录项

来源
《Paintindia》 |2003年第5期|共1页
作者
Paintindia Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类涂料工业;
关键词

相似文献

外文文献
中文文献
专利

1. Protex acquires control of Suzhou-Prox-Anli [J] . Paintindia Group Paintindia . 2003,第5期

机译：Protex取得苏州-安利-安利的控制权
2. Protex Acquires Chartwell in the U.S. [J] . Coatings World group Coatings World . 2014,第11期

机译：Protex收购了美国的Chartwell
3. Protex Acquires Mereco Technologies [J] . Coatings World group Coatings World . 2014,第11期

机译：Protex收购Mereco Technologies
4. Research on China's Antimonopoly Review of "Acquiring a small number of non-controlling equity" [C] . Zhengjia Fu, Ziqi Wang International Conference on Humanities Science and Society Development . 2018

机译：中国“收购少数非控股权益”的反垄断综述研究
5. Controlling Methicillin Resistant Staphylococcus aureus Hospital Acquired Infections: Clinical Laboratory and Infection Prevention Perspectives. [D] . Henson, Gay. 2013

机译：控制耐甲氧西林的金黄色葡萄球菌医院获得的感染：临床实验室和感染预防的观点。
6. How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections? [O] . Ala Szczepura, Susan Manzoor, Katherine Hardy, 2014

机译：参与随机对照试验的医院专业人员如何看待基因分型与PCR核糖体分型对控制医院获得性艰难梭菌感染的价值？
7. Effectiveness of a biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use: protocol for a randomised controlled trial (VAPrapid-2):Study protocol for a randomised controlled trial [O] . Hellyer, Thomas P., Anderson, Niall H., Parker, Jennie, 2016

机译：基于生物标志物排除呼吸机获得性肺炎以减少抗生素使用的有效性：一项随机对照试验的方案（VAPrapid-2）：一项随机对照试验的研究方案

Protex acquires control of Suzhou-Prox-Anli

摘要

著录项

相似文献

相关主题

期刊订阅